Click here to create your personal news page. The news that appears on Health Industries will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. LG X110
  2. 2. PowerColor Radeon HD 4870 1GB
  3. 3. Panasonic Lumix FX150
  4. 4. Panasonic Lumix FZ28
  5. 5. Gigabyte iSolo 3314
  6. 6. Panasonic Lumix LX3
  7. 7. Sapphire Radeon HD 4870 1GB
  8. go to Shopping

Participate



Health Industries


Sort by : relevance - date - popularity
+Vote!

Kennet cible les sociétés à forte croissance avec son troisième fonds

LONDRES ET SILICON VALLEY, Californie--(BUSINESS WIRE)--Kennet Partners, la firme de financement par capitaux propres qui investit dans les sociétés en pleine croissance proposant des

+Vote!

Invacare Corporation Reports Strong Second Quarter Results

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced its financial results for the second quarter and six months ended June 30, 2008.

+Vote!

Pawfect Foods anuncia adquisición de Synergy Pharmaceuticals y financiación de 3 millones de dólares

NUEVA YORK--(BUSINESS WIRE)--Pawfect Foods, Inc., corporación de Florida (PWFF.OB), ha anunciado la adquisición de Synergy Pharmaceuticals, Inc. a cambio de una parte de sus

+Vote!

Pawfect Foods kondigt overname van Synergy Pharmaceuticals en financiering van $ 3,0 miljoen aan

NEW YORK--(BUSINESS WIRE)--Pawfect Foods, Inc., een vennootschap uit de Amerikaanse staat Florida (PWFF.OB), kondigde vandaag aan dat zij Synergy Pharmaceuticals, Inc. heeft overgenomen in

+Vote!
+Vote!

Cara Therapeutics Secures $12.3 Million in Series C Extension Financing

SHELTON, Conn., July 24 /PRNewswire/ -- Cara Therapeutics, Inc. announced today that it had closed on $12.3 million of additional funding to its original $24 million Series C financing which was completed in 2007. The round was led by new investor, Devon Park Bioventures, and included participation by Connecticut Innovations. Previous investors participating in the round included; Ascent Biomedical...

+Vote!

Three Novalis Tx(TM) Radiosurgery Platforms Ordered by Top Danish Cancer Hospital

COPENHAGEN, Denmark, July 24 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: ) and BrainLAB AG are announcing that one of Scandinavia's leading cancer centers has ordered three Novalis Tx(TM) radiosurgery platforms which combine the most advanced technologies from both companies to offer superior non-invasive radiosurgery for patients. Rigshospitalet in Copenhagen has ordered two new Novalis...

+Vote!

Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31

SOUTH SAN FRANCISCO, Calif., July 24 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: ), a biopharmaceutical company focused on oncology, today announced that it will hold a conference call to discuss the Company's second quarter results and provide a corporate update, including an update on the clinical development plan for picoplatin, the Company's lead product candidate. Jerry McMahon,...

+Vote!

NxStage Appoints Jonathan Silverstein to Board of Directors

LAWRENCE, Mass., July 24 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: ), a leading manufacturer of innovative dialysis products, today announced the addition of Jonathan Silverstein, General Partner of OrbiMed Advisors, LLC, ("OrbiMed"), to its Board of Directors. NxStage elected a representative from OrbiMed to its Board in connection with the recently announced private placement. The...

+Vote!

MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis

NEW YORK, July 24 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM) today announced results of a Phase 2 clinical trial involving 37 patients who completed a 48-week, U.S. multi-center, open-label efficacy and safety study of EcoNail, a topical antifungal lacquer for the treatment of onychomycosis (nail fungus). The composite primary efficacy endpoint of the trial was "complete...

+Vote!

PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery

- Tissue Dissection System Represents Important Advance in Radiofrequency Surgical Technologies - PALO ALTO, Calif., July 24 /PRNewswire/ -- PEAK Surgical, Inc., a medical device company that has developed a new tissue dissection system based on a proprietary technology, today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its PEAK(R) Surgery...

+Vote!

Xoft Recognized With R&D 100 Award

R&D Magazine Selects Axxent(R) Miniature Brachytherapy X-ray Source as One of the 100 Most Technologically Significant Products of the Past Year SUNNYVALE, Calif., July 24 /PRNewswire/ -- Xoft, Inc. today announced that the Axxent(R) High Dose Rate (HDR) X-ray Source has been selected to receive an R&D 100 Award from R&D Magazine as one of the year's most technologically significant products. Established...

+Vote!

Sonic Innovations Appoints New Vice President of Auditory Research

SALT LAKE CITY, July 24 /PRNewswire-FirstCall/ -- Sonic Innovations, Inc. (Nasdaq: ), the only U.S.-based publicly traded manufacturer of digital hearing aids, has appointed Dr. Michael Nilsson as vice president of Auditory Research and director of the Center for Amplification and Hearing Research. Nilsson holds a bachelor's, master's and Ph.D. in Cognitive Science from the University of California. ...

+Vote!

ImClone Systems Reports Second Quarter 2008 Financial Results

NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced its

+Vote!

Applied Biosystems Reports Financial Results for Fourth Quarter and Fiscal 2008

FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE: ABI) today reported net revenues of $609.0 million for the fourth quarter of fiscal 2008, an increase of approximately 9% over